.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

AVINZA Drug Profile

« Back to Dashboard
Avinza is a drug marketed by King Pharms Llc and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has twelve patent family members in twelve countries.

The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: AVINZA

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Drug Prices: :see details

Pharmacology for Tradename: AVINZA

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-001Mar 20, 2002DISCNNo6,066,339► subscribeY ► subscribe
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-006Dec 18, 2008DISCNNo6,066,339► subscribeY ► subscribe
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-005Dec 18, 2008DISCNNo6,066,339► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: AVINZA

Drugname Dosage Strength RLD Submissiondate
morphine sulfateExtended-release Capsules45 mg and 75 mgAvinza7/30/2009
morphine sulfateExtended-release Capsules30 mg, 60 mg, 90 mg and 120 mgAvinza6/4/2007

International Patent Family for Tradename: AVINZA

Country Document Number Estimated Expiration
Spain2199378► subscribe
Taiwan520298► subscribe
Portugal1023051► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc